Fluvastatin

This classification denotes a hmg-coa reductase inhibitor with the molecular formula C24H26FNO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4L066368AS, chemically known as (3r,5s)-fluvastatin but generally known as fluvastatin, which bears US NIH Compound Identifier 446155. European Medicines Agency schedules Fluvastatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07768MIG. The term FLUVASTATIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules fluvastatin in its Anatomical Therapeutic Chemical (ATC) Classification. FLUVASTATIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluvastatin under HS 29339990 and SITC 51577. As of Q4 2014, FLUVASTATIN remains the US FDA Preferred Term for this commodity. Fluvastatin bears US NLM identifiers UMLS ID C0082608 and NCI Concept Code C61768. SMILES: Fc1ccc(c2c(n(C(C)C)c3c2cccc3)/C=C/C(O)CC(O)CC(=O)O)cc1.